Literature DB >> 12395133

Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease.

Gilbert J Ho1, Lawrence A Hansen, Michael F Alford, Katherine Foster, David P Salmon, Douglas Galasko, Leon J Thal, Eliezer Masliah.   

Abstract

This study investigated the influence of age at onset on cognitive performance, neuropathological and neurochemical features in autopsy-confirmed sporadic Lewy body variant (LBV) and in Alzheimer's disease (AD). We compared 28 early-onset (< or = 70 years) LBV subjects with 28 matched late-onset (> 70 years) subjects. Similarly, we examined the same features in 89 early onset AD and 89 matched late onset AD patients. Patients with early onset LBV and early onset AD declined more rapidly, had more neuritic plaques, and greater neocortical cholinergic loss compared to late onset LBV and late onset AD subjects. Taken together, these results suggest that for both LBV and AD, earlier age at onset may predict a more aggressive disease course. Copyright 2002 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395133     DOI: 10.1097/00001756-200210070-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  21 in total

1.  Forward telescoping bias in reported age of onset: an example from cigarette smoking.

Authors:  Eric O Johnson; Lonni Schultz
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

2.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

3.  Stable size distribution of amyloid plaques over the course of Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew L Mielke; Alona Muzitansky; Teresa Gómez-Isla; John H Growdon; Brian J Bacskai; Rebecca A Betensky; Matthew P Frosch; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

4.  Motor signs predict poor outcomes in Alzheimer disease.

Authors:  N Scarmeas; M Albert; J Brandt; D Blacker; G Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; D Wegesin; K Marder; K Bell; L Honig; Y Stern
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

5.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

6.  Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.

Authors:  Jacqueline E Maye; Rebecca A Betensky; Christopher M Gidicsin; Joseph Locascio; J Alex Becker; Lesley Pepin; Jeremy Carmasin; Dorene M Rentz; Gad A Marshall; Deborah Blacker; Reisa A Sperling; Keith A Johnson
Journal:  Neurobiol Aging       Date:  2015-12-28       Impact factor: 4.673

7.  Medial temporal atrophy in early and late-onset Alzheimer's disease.

Authors:  Enrica Cavedo; Michela Pievani; Marina Boccardi; Samantha Galluzzi; Martina Bocchetta; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2014-03-15       Impact factor: 4.673

8.  The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.

Authors:  Brandon E Gavett; Samantha E John; Ashita S Gurnani; Cara A Bussell; Jessica L Saurman
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

9.  Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Authors:  Meredith L Phillips; Eddie C Stage; Kathleen A Lane; Sujuan Gao; Shannon L Risacher; Naira Goukasian; Andrew J Saykin; Maria C Carrillo; Bradford C Dickerson; Gil D Rabinovici; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2020-01-03       Impact factor: 2.959

10.  The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.

Authors:  So-Hee Park; Eun-Hye Lee; Hyung-Ji Kim; Sungyang Jo; Sunju Lee; Sang Won Seo; Hyun-Hee Park; Seong-Ho Koh; Jae-Hong Lee
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.